APLM Stock Analysis: Buy, Sell, or Hold?
$23.11
-1.22 (-5.02%)
▼
5d:
-1.88%
30d:
+22.52%
90d:
+61.49%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Jul 24, 2026
0d
Get Alerted When APLM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: APLM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: APLM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: APLM is currently trading at $23.11, which is considered extended relative to its 30-day fair value range of $16.78 to $22.04.
Technical Outlook: Technically, APLM is in a strong uptrend. Immediate support is located at $16.70, while resistance sits at $27.16. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: APLM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APLM is in a strong uptrend. Immediate support is located at $16.70, while resistance sits at $27.16. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: APLM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.78 -
$22.04
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BEARISH: Trading 91.3% above Wall St target ($2.00)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.78 -
$22.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.70
Resistance Level
$27.16
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Wall Street Target
$2.00
(-91.3%)
Revenue Growth (YoY)
380.8%
Profit Margin
-123.7%
Share & Embed Analysis
Last updated: August 25, 2026 9:03 AM ET
Data refreshes hourly during market hours. Next update: 10:03 AM
Data refreshes hourly during market hours. Next update: 10:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APLM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |